Combating the emergence and spread of antimicrobial resistant infectious diseases in Vietnam: the V-RESIST study
Lead: Associate Professor Gregory Fox, University of Sydney
Drug resistant infections are on the rise across the Indo-Pacific region, leading to poor treatment outcomes. Drug resistant tuberculosis and respiratory pathogens are increasingly common, and pose a major threat to health in Vietnam and the region. Antimicrobial resistant infectious (AMR) diseases are also a top priority for Vietnam, topping its list of priorities in the 2015 Vietnam Global Health Security Roadmap.
This three-year project will execute a program of research to develop and assess the effectiveness of a package of interventions to guide the Vietnamese government in combating the drivers of antimicrobial resistance. This study will help to understand and target the drivers of drug resistance, and ultimately preserve the effectiveness of life-saving antibiotics.
The project will be done in 36 Districts in population of over five million people.
- University of New South Wales
- Burnet Institute
- University of Melbourne
- Australian National University
- Hanoi Medical University, Vietnam
- Vietnam Ministry of Health
- National Lung Hospital, Vietnam
- National Institute of Hygiene and Epidemiology, Vietnam
- Pasteur Institute, Vietnam
- Health Strategy and Policy Institute, Vietnam
- Oxford University Clinical Research Unit, Vietnam
- Medicine and Pharmacy University, Vietnam
- Karolinska Institutet, Sweden
- Woolcock Institute of Medical Research Limited